Securian Asset Management Inc. Lowers Holdings in UnitedHealth Group Incorporated $UNH

Key Points

• Securian Asset Management Inc. reduced its stake in UnitedHealth Group by 2.8%, holding 47,428 shares worth approximately $14.8 million.
• Analysts have rated UnitedHealth Group's stock favorably, with an average rating of Hold and a consensus price target of $385.13.
• The company reported earnings of $4.08 per share last quarter, missing estimates, while setting a fiscal year 2025 guidance of 16.000 EPS.

Securian Asset Management Inc. decreased its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 2.8% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 47,428 shares of the healthcare conglomerate's stock after selling 1,345 shares during the quarter. Securian Asset Management Inc.'s holdings in UnitedHealth Group were worth $14,796,000 as of its most recent SEC filing.

A number of other hedge funds have also recently modified their holdings of UNH. Nuveen LLC purchased a new stake in shares of UnitedHealth Group in the first quarter worth about $3,846,764,000. Vanguard Group Inc. raised its holdings in UnitedHealth Group by 6.6% in the 1st quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate's stock worth $47,519,620,000 after purchasing an additional 5,583,343 shares during the period. Wellington Management Group LLP raised its holdings in UnitedHealth Group by 10.6% in the 1st quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate's stock worth $13,537,859,000 after purchasing an additional 2,486,839 shares during the period. National Bank of Canada FI raised its holdings in UnitedHealth Group by 137.8% in the 1st quarter. National Bank of Canada FI now owns 1,641,177 shares of the healthcare conglomerate's stock worth $859,518,000 after purchasing an additional 950,928 shares during the period. Finally, Charles Schwab Investment Management Inc. raised its holdings in UnitedHealth Group by 13.6% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 7,070,385 shares of the healthcare conglomerate's stock worth $3,702,736,000 after purchasing an additional 847,054 shares during the period. Hedge funds and other institutional investors own 87.86% of the company's stock.

Analyst Ratings Changes

A number of equities analysts recently weighed in on the company. The Goldman Sachs Group assumed coverage on UnitedHealth Group in a report on Tuesday, October 14th. They issued a "buy" rating and a $406.00 price target for the company. Bank of America increased their target price on UnitedHealth Group from $350.00 to $390.00 and gave the company a "neutral" rating in a report on Wednesday, October 8th. Cantor Fitzgerald reissued an "overweight" rating and set a $440.00 target price on shares of UnitedHealth Group in a report on Tuesday, August 26th. Morgan Stanley increased their target price on UnitedHealth Group from $325.00 to $395.00 and gave the company an "overweight" rating in a report on Friday, September 12th. Finally, Baird R W cut UnitedHealth Group from a "hold" rating to a "strong sell" rating in a report on Thursday, July 31st. Eighteen investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and four have assigned a Sell rating to the stock. According to MarketBeat.com, UnitedHealth Group currently has an average rating of "Hold" and a consensus price target of $385.13.

UnitedHealth Group Price Performance

NYSE:UNH opened at $364.31 on Tuesday. The stock has a market cap of $329.95 billion, a PE ratio of 15.78, a P/E/G ratio of 2.31 and a beta of 0.47. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $630.73. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The stock has a 50 day moving average price of $331.62 and a 200 day moving average price of $341.12.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). The business had revenue of $111.62 billion during the quarter, compared to analysts' expectations of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company's revenue was up 12.9% on a year-over-year basis. During the same quarter in the previous year, the company posted $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Equities research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were given a $2.21 dividend. This represents a $8.84 annualized dividend and a yield of 2.4%. The ex-dividend date was Monday, September 15th. UnitedHealth Group's dividend payout ratio is presently 38.30%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.